000 01630 a2200397 4500
005 20250515000911.0
264 0 _c20070919
008 200709s 0 0 eng d
022 _a0167-6806
024 7 _a10.1007/s10549-005-7728-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPorter, Joseph F
245 0 0 _aTissue inhibitor of metalloproteinases-1 stimulates gene expression in MDA-MB-435 human breast cancer cells by means of its ability to inhibit metalloproteinases.
_h[electronic resource]
260 _bBreast cancer research and treatment
_cNov 2005
300 _a185-93 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xmetabolism
650 0 4 _aCell Line, Tumor
_xdrug effects
650 0 4 _aDNA Primers
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aMetalloproteases
_xantagonists & inhibitors
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTissue Inhibitor of Metalloproteinase-1
_xadministration & dosage
700 1 _aSharma, Shashi
700 1 _aWilson, Donna L
700 1 _aKappil, Maya A
700 1 _aHart, Ronald P
700 1 _aDenhardt, David T
773 0 _tBreast cancer research and treatment
_gvol. 94
_gno. 2
_gp. 185-93
856 4 0 _uhttps://doi.org/10.1007/s10549-005-7728-4
_zAvailable from publisher's website
999 _c15777912
_d15777912